Beckley Psytech Limited clinical trials
Acquired by Eli Lilly and Company, Sep 11, 2026 · source ↗
The registry lists 6 studies whose lead sponsor is Beckley Psytech Limited. 1 is recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 10, 2026.
- 6studies on the registry
- 1open to participants now
- 1reach primary completion within a year
Before and after it joined Eli Lilly and Company
- First submitted before Beckley Psytech Limited became part of Eli Lilly and Company
- 6
- First submitted after Beckley Psytech Limited became part of Eli Lilly and Company
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Beckley Psytech Limited’s studies test, most open studies first — 3 drugs with a page of their own. Each count opens the studies in search.
Open now Not open: under way, finished or stopped
Coming up
1 of Beckley Psytech Limited’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.
Phase 3 Other phases
- 1NNov ’26’26
- DDec
- JJan ’27’27
- FFeb
- MMar
- AApr
- MMay
- JJun
- JJul
- AAug
- SSep
- OOct
- NNov
The study
Add it to your calendar (.ics) → With an account.
All 6 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 21
- 22
- 323
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Beckley Psytech Limited6 studies
Something wrong with this grouping? Tell us on the Eli Lilly and Company page.
Studies
Recruiting first, then most recently updated. Showing 6 of 6. All Eli Lilly and Company studies →
- An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant DepressionRecruitingNCT05660642Phase 2
Sponsor listed in the registry: Beckley Psytech Limited · First submitted before Beckley Psytech Limited became part of Eli Lilly and Company
- BPL-003 Efficacy and Safety in Treatment Resistant DepressionCompletedNCT05870540Phase 2
Sponsor listed in the registry: Beckley Psytech Limited · First submitted before Beckley Psytech Limited became part of Eli Lilly and Company
- An Open-Label, Single Dose Study in Patients With Alcohol Use DisorderCompletedNCT05674929Phase 2
Sponsor listed in the registry: Beckley Psytech Limited · First submitted before Beckley Psytech Limited became part of Eli Lilly and Company
- Single Ascending Dose Study With BPL-003 in Healthy SubjectsCompletedNCT05347849Phase 1
Sponsor listed in the registry: Beckley Psytech Limited · First submitted before Beckley Psytech Limited became part of Eli Lilly and Company
- Phase 1b Study in Patients With Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)TerminatedNCT04905121Phase 1
Sponsor listed in the registry: Beckley Psytech Limited · First submitted before Beckley Psytech Limited became part of Eli Lilly and Company
- Single Ascending Dose Study With 5-MeO-DMT in Healthy SubjectsCompletedNCT05032833Phase 1
Sponsor listed in the registry: Beckley Psytech Limited · First submitted before Beckley Psytech Limited became part of Eli Lilly and Company